Importance Survival outcomes for anaplastic thyroid cancer (ATC), the most aggressive
subtype of thyroid cancers, have remained poor. However, targeted therapies and …

Introduction Although anaplastic thyroid carcinoma (ATC) is rare, it is one of the most
aggressive human cancers. The optimal multimodal therapy policy of ATC is still debated …

Anaplastic thyroid cancer is a rare but nearly universally fatal tumor. Epidemiologic data
suggest that many anaplastic thyroid carcinomas arise from transformation of preexisting or …

Anaplastic thyroid cancer (ATC) is associated with an extremely poor prognosis and is
resistant to the majority of chemotherapies. In 2015, lenvatinib was approved for treating …

ABSTRACT Background The Korean Society of Thyroid Head and Neck Surgery established
a nationwide multicenter registry of anaplastic thyroid carcinoma (ATC) and evaluated the …

Objective Anaplastic thyroid cancer (ATC) is often inoperable and chemotherapy and
radiotherapy are the main treatments. Until now,'primary ATC cell cultures'(ANA) have been …

Objective Treatment options for anaplastic thyroid carcinoma (ATC), which is one of the most
lethal human malignant tumors, include surgery, chemotherapy and radiotherapy usually …

The initial management of thyroid cancer is usually surgery, followed by radioactive iodine in
differentiated thyroid cancer. The role of external beam radiotherapy for gross residual or …

Conclusion Thyroid cancer comprises a group of tumors with remarkably different features.
Owing to the rising incidence of thyroid cancer and recent advances in the management of …

Introduction Few available data indicate that a mutation-based “neoadjuvant” therapy in
advanced anaplastic thyroid carcinoma (ATC) might convert an initially unresectable primary …